PenSemax 10 mg
An ACTH-derived peptide studied for nootropic and neuroprotective research.
PE-22-28 PENCognition · Neuropeptide
A synthetic analog of spadin studied for blocking TREK-1 potassium channels, with research interest in neuroplasticity, mood and antidepressant endpoints.
Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.
PE-22-28 is a shortened analog of the natural peptide spadin, studied for inhibiting TREK-1 channels and promoting neuroplasticity, with research interest in fast-acting antidepressant models.
Features
PE-22-28 is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
PenAn ACTH-derived peptide studied for nootropic and neuroprotective research.
PenAn angiotensin-IV-derived peptide studied for synaptogenesis and cognition research.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.